Larvol Delta - Regulus-Therapeutics-presents-preclinical-data-identifying-RGLS4326-as-a-potential-diseasemodifying-treatment-for-autosomal-dominant-polycystic-kidney-disease-at-OTS-Annual-Meeting

RGLS4326 - Regulus Therapeutics

https://www.prnewswire.com/news-releases/regulus-therapeutics-presents-preclinical-data-identifying-rgls4326-as-a-potential-disease-modifying-treatment-for-autosomal-dominant-polycystic-kidney-disease-at-ots-annual-meeting-300939940.html

Oct 16, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next